CSPC PHARMACEUTICAL GROUP ADR (CSPCY)
Institutional ownership reported to the SEC as of Q2 2026, across 29 quarters.
2
Reporting holders
$7.4K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | $6.9K | 1,965 | 0.00% | 13q | HELD |
| PNC Financial Services Group, Inc. | $505 | 144 | 0.00% | 21q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2 | $7.4K | 2,109 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 2 | $9.8K | 2,109 | 0 | 0 | 2 | 0.0% |
| Q4 2025 | 2 | $17.5K | 4,057 | 0 | 1 | 0 | 0.0% |
| Q3 2025 | 2 | $10.3K | 2,188 | 0 | 0 | 1 | 0.0% |
| Q2 2025 | 2 | $8.9K | 2,271 | 0 | 1 | 1 | 0.0% |
| Q1 2025 | 2 | $5.8K | 2,282 | 0 | 1 | 1 | 0.0% |
| Q4 2024 | 2 | $61.8K | 26,190 | 0 | 0 | 1 | 0.0% |
| Q3 2024 | 2 | $78.6K | 26,296 | 0 | 0 | 1 | 0.0% |
| Q2 2024 | 2 | $82.2K | 26,417 | 0 | 1 | 0 | 0.0% |
| Q1 2024 | 3 | $88.0K | 28,306 | 0 | 1 | 0 | 0.0% |
| Q4 2023 | 3 | $104.4K | 28,289 | 0 | 0 | 1 | 0.0% |
| Q3 2023 | 4 | $227.2K | 78,761 | 1 | 1 | 1 | 0.0% |
| Q2 2023 | 4 | $2.1M | 604,577 | 1 | 1 | 2 | 0.0% |
| Q1 2023 | 4 | $4.1M | 1,033,149 | 1 | 1 | 1 | 0.0% |
| Q4 2022 | 4 | $310.0K | 576,365 | 2 | 1 | 1 | 0.0% |
| Q3 2022 | 3 | $2.2M | 550,624 | 0 | 1 | 2 | 0.0% |
| Q2 2022 | 5 | $2.9M | 720,386 | 0 | 3 | 0 | 0.0% |
| Q1 2022 | 5 | $2.8M | 602,861 | 1 | 3 | 0 | 0.0% |
| Q4 2021 | 4 | $2.3M | 539,796 | 1 | 1 | 2 | 0.0% |
| Q3 2021 | 5 | $3.0M | 620,420 | 2 | 2 | 1 | 0.0% |
| Q2 2021 | 3 | $4.0M | 684,746 | 1 | 1 | 1 | 0.0% |
| Q1 2021 | 2 | $3.1M | 644,954 | 1 | 0 | 1 | 0.0% |
| Q4 2020 | 1 | $3.0M | 736,327 | 0 | 1 | 0 | 0.0% |
| Q3 2020 | 1 | $1.4M | 181,420 | 0 | 1 | 0 | 0.0% |
| Q2 2020 | 2 | $1.0M | 135,929 | 1 | 1 | 0 | 0.0% |
| Q1 2020 | 1 | $478.0K | 59,722 | 1 | 0 | 0 | 0.0% |
| Q3 2019 | 2 | $702.0K | 87,396 | 1 | 1 | 0 | 0.0% |
| Q2 2019 | 1 | $343.0K | 53,158 | 0 | 1 | 0 | 0.0% |
| Q1 2019 | 1 | $333.0K | 44,753 | 1 | 0 | 0 | 0.0% |